文献速递前列腺癌

弹性磁共振-经直肠超声融合活检对活检初治男性临床显著前列腺癌ISUP分级一致性的比较影响

Comparative Impact of Elastic Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy on Concordance of Detection of Clinically Significant Prostate Cancer by International Society of Urological Pathology Grade in Biopsy-naïve Men with Prostate-specific Antigen ≤20 ng/ml and cT1-2 Disease.
PubMed 文献 · Eur Urol Oncol · 2025-09-19

该多中心回顾性研究纳入888例活检初治确诊前列腺癌男性(PSA≤20 ng/ml,cT1-2,PI-RADS 3-5),比较弹性配准技术(ERT)与刚性配准技术(RRT)对靶向活检与整体活检在临床显著前列腺癌(csPC,ISUP≥2)和高分级前列腺癌(hgPC,ISUP≥3)检测一致性的影响。经倾向性评分匹配后674例分析显示,ERT组csPC一致性显著高于RRT组(60.2% vs 33.6%,p<0.0001),且ERT与更高的一致性几率相关。

要点

  • ERT组csPC一致性为60.2%,显著高于RRT组的33.6%(p<0.0001)。
  • ERT与csPC一致性独立相关(aOR 4.82,95%CI 2.82-8.24)。
  • ERT减少ISUP 1级病变的过度分级(12.5% vs 39.2%,p<0.001)。

核心结论

  • ERT与靶向活检检测csPC和hgPC的更好一致性相关,支持更准确的风险分层并减少惰性癌检测。

研究设计与样本

  • 多中心回顾性研究纳入888例活检初治确诊前列腺癌男性(PSA≤20 ng/ml,cT1-2,PI-RADS 3-5),接受ERT(n=479)或RRT(n=409)。
  • 经1:1倾向性评分匹配后,674例患者纳入最终分析。

主要发现

  • ERT组与RRT组csPC一致性频率分别为60.2%和33.6%,差异显著(p<0.0001)。
  • ERT与csPC一致性分类的调整比值比为4.82(95%CI 2.82-8.24)。
  • ERT减少ISUP 1级病变的过度分级(12.5% vs 39.2%,p<0.001)。
  • 尽管核心体积更低且阳性针数更少,ERT达到相似的最大癌核心长度;PI-RADS 3亚组分析显示ERT有利趋势但无统计学显著性(p>0.05)。

关键数值与推荐

  • csPC定义为ISUP分级≥2,hgPC定义为ISUP分级≥3。
  • 纳入标准:PSA≤20 ng/ml,cT1-2,PI-RADS评分3-5。

临床怎么用

  • 在活检初治男性中,优先选择弹性配准技术进行MRI-TRUS融合活检可能提高csPC和hgPC的ISUP分级一致性,减少过度分级。

局限性

  • 回顾性研究设计,需前瞻性多中心研究及中心化病理复核进行外部验证和评估下游临床影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) fusion guided biopsy is the cornerstone of prostate cancer (PC) diagnosis. While prior studies have focused on detection rates, the impact of fusion registration methods-elastic registration techniques (ERT) versus rigid registration techniques (RRT)-on International Society of Urological Pathology (ISUP) grade concordance remains underexplored. Our objectives were to assess the effect of ERT versus RRT on the concordance between targeted biopsy (TBx) and overall biopsies (OBx) for detection of (1) clinically significant PC (csPC; defined as ISUP grade ≥2) and (2) high-grade PC (hgPC; defined as ISUP grade ≥3) in biopsy-naïve men with confirmed PC. METHODS: Our multicenter retrospective study included 888 biopsy-naïve men with confirmed PC (prostate-specific antigen ≤20 ng/ml, cT1-2, Prostate Imaging-Reporting and Data System [PI-RADS] score 3-5) who underwent MRI-TRUS fusion guided biopsy using ERT (n = 479) or RRT (n = 409) at two high-volume institutions. After 1:1 propensity score matching (PSM) to control for confounding, a sample of 674 patients was included in the final analysis. The primary endpoint was the concordance of csPC detection between TBx and OBx. Secondary endpoints included concordance for hgPC detection (ISUP grade ≥3) between TBx and OBx, concordance for hgPC (ISUP grade ≥3) between systematic biopsy (SBx) and OBx, biopsy sampling metrics, and subgroup analyses for PI-RADS 3 lesions. Multivariable logistic binomial regression models adjusted for clinical and imaging covariates were tested. KEY FINDINGS AND LIMITATIONS: There was a significant difference in the frequency of csPC concordance between the ERT and RRT groups (60.2% vs 33.6%; p < 0.0001). Moreover, the ERT approach was associated with significantly higher odds of being classified as concordant csPC in comparison to RRT (adjusted odds ratio [aOR] 4.82, 95% confidence interval 2.82-8.24). ERT was also significantly associated with higher odds of hgPC concordance after adjusting for PSA density, clinical TNM stage and PI-RADS score (aOR 2,51, 95% confidence interval 1.51-4.16; corrected p = 0.0014). ERT reduced overgrading of ISUP grade 1 lesions (12.5% vs 39.2%; p < 0.001). Despite lower core volume and fewer positive cores, ERT achieved similar maximum cancer core length, suggesting superior spatial targeting. PI-RADS 3 subgroup analyses showed favorable trends for ERT, although the results were not statistically significant (p >0.05). CONCLUSIONS AND CLINICAL IMPLICATIONS: ERT was associated with better concordance for detection of both csPC and hgPC on TBx, supporting more accurate risk stratification while reducing detection of indolent cancer. While our findings indicate diagnostic advantages for ERT over RRT, prospective multicenter studies with centralized pathology review are warranted for external validation and evaluation of the downstream clinical impact.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Buhas BA, Gregoris A, Iancu M, et al. Comparative Impact of Elastic Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy on Concordance of Detection of Clinically Significant Prostate Cancer by International Society of Urological Pathology Grade in Biopsy-naïve Men with Prostate-specific Antigen ≤20 ng/ml and cT1-2 Disease. Eur Urol Oncol. 2025. PMID: 40975636. doi:10.1016/j.euo.2025.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。